Evidence map›Paper›PMID 33572661›Full record

ReviewNutrients2021

Gut Hormones in Health and Obesity: The Upcoming Role of Short Chain Fatty Acids.

Habeeb Alhabeeb, Ali AlFaiz, Emad Kutbi, Dayel AlShahrani, Abdullah Alsuhail, Saleh AlRajhi, Nemer Alotaibi, Khalid Alotaibi, Saad AlAmri, Saleh Alghamdi and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Host-Microbiota Interactions in Obesity: Immune Metabolic Dysregulation.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Intestinal-related substances in obesity regulation: A comprehensive review.World journal of gastrointestinal pharmacology and therapeutics · 2025
    Review
  11. Review
  12. GD2TNature communications · 2025
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Habeeb AlhabeebResearch Center, King Fahad Medical City-KFMC, Riyadh 11525, Saudi Arabia.ORCID 0000-0001-5573-8887
Ali AlFaizResearch Center, King Fahad Medical City-KFMC, Riyadh 11525, Saudi Arabia.
Emad KutbiResearch Center, King Fahad Medical City-KFMC, Riyadh 11525, Saudi Arabia.
Dayel AlShahraniResearch Center, King Fahad Medical City-KFMC, Riyadh 11525, Saudi Arabia.
Abdullah AlsuhailResearch Center, King Fahad Medical City-KFMC, Riyadh 11525, Saudi Arabia.
Saleh AlRajhiFamily Medicine, King Fahad Medical City-KFMC, Riyadh 11525, Saudi Arabia.
Nemer AlotaibiCollege of Medicine, Shaqra University, Shaqra 11961, Saudi Arabia.
Khalid AlotaibiCollege of Medicine, Shaqra University, Shaqra 11961, Saudi Arabia.
Saad AlAmriResearch Center, King Fahad Medical City-KFMC, Riyadh 11525, Saudi Arabia.
Saleh AlghamdiResearch Center, King Fahad Medical City-KFMC, Riyadh 11525, Saudi Arabia.
Naji AlJohaniObesity, Endocrine, and Metabolism Center, King Fahad Medical City-KFMC, Riyadh 11525, Saudi Arabia.
King Fahd Medical City · SAShaqra University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We are currently facing an obesity pandemic, with worldwide obesity rates having tripled since 1975. Obesity is one of the main risk factors for the development of non-communicable diseases, which are now the leading cause of death worldwide. This calls for urgent action towards understanding the underlying mechanisms behind the development of obesity as well as developing more effective treatments and interventions. Appetite is carefully regulated in humans via the interaction between the central nervous system and peripheral hormones. This involves a delicate balance in external stimuli, circulating satiating and appetite stimulating hormones, and correct functioning of neuronal signals. Any changes in this equilibrium can lead to an imbalance in energy intake versus expenditure, which often leads to overeating, and potentially weight gain resulting in overweight or obesity. Several lines of research have shown imbalances in gut hormones are found in those who are overweight or obese, which may be contributing to their condition. Therefore, this review examines the evidence for targeting gut hormones in the treatment of obesity by discussing how their dysregulation influences food intake, the potential possibility of altering the circulating levels of these hormones for treating obesity, as well as the role of short chain fatty acids and protein as novel treatments.

Indexed as

Acetic AcidAnimalsAppetiteAppetite RegulationButyratesCentral Nervous SystemCholecystokininDipeptidesEnergy IntakeEnergy MetabolismFatty Acids, VolatileGastrointestinal HormonesGastrointestinal TractGhrelinGlucagon-Like Peptide 1HumansAcetic AcidButyratesCholecystokininDipeptidesFatty Acids, VolatileGastrointestinal HormonesGhrelinGlucagon-Like Peptide 1Neuropeptide YOxyntomodulinPancreatic PolypeptidePropionatestyrosyltyrosineappetitediabetesfood intakeglucagon-like peptide-1gut hormonesneuropeptide Yobesityoverweightpeptide tyrosine tyrosineshort chain fatty acids

Identifiers

PMID33572661
PMCPMC7911102
OpenAlexW3128500266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.